4//SEC Filing
Douville Philippe 4
Accession 0001209191-19-029668
CIK 0001408443other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:35 PM ET
Size
7.1 KB
Accession
0001209191-19-029668
Insider Transaction Report
Form 4
Douville Philippe
Chief Scientific Officer
Transactions
- Conversion
Common Shares
2019-05-13+4,124→ 43,392 total - Conversion
Class A-1 Preferred
2019-05-13−4,124→ 0 total→ Common Shares (4,124 underlying)
Footnotes (1)
- [F1]Each share of Class A-1 Preferred was convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, had no expiration date and converted into Common Shares upon the closing of the Issuer's initial public offering.
Documents
Issuer
Milestone Pharmaceuticals Inc.
CIK 0001408443
Entity typeother
Related Parties
1- filerCIK 0001771205
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 4:35 PM ET
- Size
- 7.1 KB